Spruce Biosciences has named Dale Hooks chief commercial officer, securing a leader with experience launching 21 products as the company heads toward a filing for its first FDA approval.

Science is messy business. Finding the truth is easier said than done.

Biologics License Application (BLA) Submission to U.S. FDA for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Anticipated in 1H 2026 Spruce to Host Conference Call Today at 8:30 a.m. ET "This ...

Minnesota Department of Natural Resources conservation officer Shane Zavodnik examines an illegally cut spruce tree while standing in a frozen swamp in late November, on private property near Eveleth.